Excretory-secretory products secreted by Paragonimus westermani delay the spontaneous cell death of human eosinophils through autocrine production of GM-CSF

International Archives of Allergy and Immunology

Volumn 132, Issue 1, 2003, Pages 48-57

  Shin, Myeong Heon ^a   Seoh, Ju Young ^b   Park, Hae Young ^b   Kita, Hirohito ^c  

^a Yonsei University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c MAYO CLINIC   (United States)

Author keywords

Eosinophils; Excretory secretory products; GM CSF; Paragonimus westermani; Survival

Indexed keywords

EXCRETORY SECRETORY PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HELMINTH PROTEIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHOTRANSFERASE INHIBITOR; PROPIDIUM IODIDE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BLOOD DONOR; CELL DEATH; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PARAGONIMIASIS; PARAGONIMUS WESTERMANI; PRIORITY JOURNAL; STAINING;

ANIMALS; CELL DEATH; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HELMINTH PROTEINS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-5; LEUCINE; LUNG DISEASES; PARAGONIMIASIS; PARAGONIMUS; TYRPHOSTINS;

EID: 0141889596     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073264     Document Type: Article

References (44)

1. Gleich GJ, Adolphson CR: The eosinophilic leukocytes: Structure and function. Adv Immunol 1986;39:177-253.
2. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
3. Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PI: Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol 2000;106:77-83.
4. Ohta K, Yamashita N: Apoptosis of eosinophils and lymphocytes in allergic inflammation. J Allergy Clin Immunol 1999;104:14-21.
5. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-3908.
6. Yousefi S, Blaser K, Simon HU: Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int Arch Allergy Immunol 1997;112:9-12.
7. Tai PC, Sun L, Spry CJ: Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991;85:312-326.
8. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-2547.
9. Walsh GM, Symon FA, Wardlaw AJ: Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin Exp Allergy 1995;25:1128-1136.
10. Kim JT, Gleich GJ, Kita H: Roles of CD9 molecules in survival and activation of human eosinophils. J Immunol 1997;159:926-933.
11. Kim JT, Schimming AW, Kita H: Ligation of FcγRII (CD32) pivotally regulates survival of human eosinophils. J Immunol 1999;162:4253-4259.
12. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y: Mast cells enhance eosinophil survival in vitro: Role of TNF-αand granulocyte-macrophage colony-stimulating factor. J Immunol 1998;160:5554-5562.
13. Meerschaert J, Busse WW, Bertics PJ, Mosher DF: CD14+ cells are necessary for increased survival of eosinophils in response to lipopolysaccharide. Am J Respir Cell Mol Biol 2000;23:780-787.
14. Aga E, Katschinski DM, van Zandbergen G, Laufs H, Hansen B, Muller K, Solbach W, Laskay T: Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 2002;169:898-905.
15. Channon JY, Miselis KA, Minns LA, Dutta C, Kasper LH:Toxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: Implications for neutrophil apoptosis. Infect Immun 2002;70:6048-6057.
16. Gon S, Saito S, Takeda Y, Miyata H, Takatsu K, Sendo F: Apoptosis and in vivo distribution and clearance of eosinophils in normal and Trichinella spiralis-infected rats. J Leukoc Biol 1997;62:309-317.
17. Sugaya H, Abe T, Yoshimura K: Eosinophils in the cerebrospinal fluid of mice infected with Angiostrongylus cantonensis are resistant to apoptosis. Int J Parasitol 2001;31:1649-1658.
18. Rumbley CA, Sugaya H, Zekavat SA, Perrin PJ, Phillips SM: Elimination of lymphocytes, but not eosinophils, by Fas-mediated apoptosis in murine schistosomiasis. Am J Trop Med Hyg 2001;65:442-449.
19. Berasain P, Carmona C, Frangione B, Dalton JP, Goni F: Fasciola hepatica: Parasite-secreted proteinases degrade all human IgG subclasses: Determination of the specific cleavage sites and identification of the immunoglobulin fragments produced. Exp Parasitol 2000;94:99-110.
20. Carmona C, Dowd AJ, Smith AM, Dalton JP: Cathepsin L proteinase secreted by Fasciola hepaticain vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol Biochem Parasitol 1993;62:9-17.
21. Shin MH, Kita H, Park HY, Seoh JY: Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G. Infect Immun 2001;69:1599-1604.
22. Chung YB, Kong Y, Joo IJ, Cho SY, Kang SY: Excystment of Paragonimus westermani metacercariae by endogenous cysteine protease. J Parasitol 1995;81:137-142.
23. Shin MH, Lee SY: Proteolytic activity of cysteine protease in excretory-secretory product of Paragonimus westermani newly excysted metacercariae pivotally regulates IL-8 production of human eosinophils. Parasite Immunol 2000;22:529-533.
24. Shin MH, Min DY: Infection status of Paragonimus westermani metacercariae in crayfish (Cambaroides similis) collected from Bogildo (Islet), Wando-gun, Chollanam-do, Korea. Korean J Parasitol 1999;37:55-57.
25. Zain J, Huang YQ, Feng X, Nierodzik ML, Li JJ, Karpatkin S: Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood 2000;95:3133-3138.
26. Hiraguri M, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I: Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J Allergy Clin Immunol 1997;100:S45-S51.
27. Miike S, Nakao A, Hiraguri M, Kurasawa K, Saito Y, Iwamoto I: Involvement of JAK2, but not PI 3-kinase/Akt and MAP kinase pathways, in anti-apoptotic signals of GM-CSF in human eosinophils. J Leukoc Biol 1999;65:700-706.
28. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJB, Borger P: Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185-1193.
29. King C, Brennan S, Thompson PJ, Stewart GA: Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol 1998;161:3645-3651.
30. Lourbakos A, Potempa J, Travis J, D'Andrea MR, Andrade-Gordon P, Santulli R, Mackie EJ, Pike RN: Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001;69:5121-5130.
31. Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-1068.
32. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn ML, Nelken NA, Coughlin SR, Payan DG, Bunnett NW: Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 1996;314:1009-1016.
33. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997;386:502-506.
34. Xu WF, Anderson H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998;95:6642-6646.
35. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR: Protease-activated receptor 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999;103:879-887.
36. Nystedt S, Ramarkrishnan V, Sundelin J: The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J Biol Chem 1996;271:14910-14915.
37. Howells GL, Macey MG, Chinni C, Hou L, Fox MT, Harriott P, Stone SR: Proteinase-activated receptor-2: Expression by human neutrophils. J Cell Sci 1997;110:881-887.
38. Mari B, Guerin S, Far DF, Breitmayer JP, Belhacene N, Peyron JF, Rossi B, Auberger P: Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J 1996;10:309-316.
39. Mackie EJ, Pagel CN, Smith R, de Niese MR, Song SJ, Pike RN: Protease-activated receptors: A means of converting extracellular proteolysis into intracellular signals. IUBMB 2002;53:277-281.
40. Vliagoftis H, Befus AD, Hollenberg MD, Moqbel R: Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2. J Allergy Clin Immunol 2001;107:679-685.
41. Lindner JR, Kahn ML, Coughlin SR, Sambrano GR, Schauble E, Bernstein D, Foy D, Hafezi-Moghadam A, Ley K: Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 2000;165:6504-6510.
42. Miike S, McWilliam AS, Kita H: Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J Immunol 2001;167:6615-6622.
43. Kong Y, Chung YB, Cho SY, Kang SY: Cleavage of immunoglobulin G by excretory-secretory cathepsin S-like protease of Spirometra mansoni plerocercoid. Parasitology 1994;109:611-621.
44. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 1981;80:535-561.